FDA MedWatch Adverse Event

Related by string. * fda . FDAs . Fda : Drug Administration FDA . Receives FDA Clearance . reformulates existing FDA . FDA Orphan Drug / Medwatch . medwatch : MedWatch HF 2 . www.fda.gov medwatch . Visit www.fda.gov medwatch / ADVERSE . adverse : adverse determinations . adverse impacts . adverse effects / eventing . EVENTS . EVENT : IN NO EVENT . EVENT GIVING RISE TO . Petersen Events Center * *

Related by context. Frequent words. (Click for all words.) 63 MedWatch 62 Adverse reactions 49 adverse reactions 46 VAERS 44 Elidel 43 GEMZAR 43 hypersensitivity reactions 43 Adverse Drug 42 allergic reactions 42 orthostatic hypotension 41 angioedema 41 phenytoin 41 severe allergic reactions 41 levothyroxine 40 lacosamide 40 diarrhea nausea 40 Allergic reactions 40 abacavir 40 Adverse events 39 antiepileptic drugs 39 JANUVIA 39 thromboembolic events 39 Discontinuation 39 headache nausea 39 SAEs 39 liver toxicity 39 ACTEMRA 39 amiodarone 39 ketoconazole 38 nausea diarrhea 38 milligram doses 38 Neupro ® 38 Ortho Evra 38 Cleviprex 38 renal impairment 38 anakinra 38 excessive sleepiness 38 hepatotoxicity 37 venlafaxine 37 postmarketing 37 stimulant medications 37 events AEs 37 tardive dyskinesia 37 colchicine 37 severe renal impairment 37 BOTOX R 37 musculoskeletal pain 37 mg dose 36 revaccinated 36 containing acetaminophen 36 fingolimod 36 ADHD medications 36 nausea vomiting diarrhea 36 SPRYCEL 36 Mylotarg 36 ONGLYZA 36 FENTORA 36 VYTORIN 36 lamotrigine 36 gastrointestinal symptoms 35 BARACLUDE 35 warfarin 35 NSAID 35 liver dysfunction 35 atazanavir 35 macular edema 35 RotaTeq 35 PDE5 inhibitors 35 Exjade 35 isotretinoin 35 adalimumab 35 TNF blockers 35 febuxostat 34 paroxetine 34 heavy menstrual bleeding 34 acetaminophen 34 adverse effects 34 Cimzia ® 34 hypoglycemia 34 metoclopramide 34 contraindication 34 threatening allergic reactions 34 hypercalcemia 34 cardiac toxicity 34 TORISEL 34 events SAEs 34 infusion reactions 33 treatment emergent adverse 33 Digitek 33 discontinuations due 33 CIMZIA 33 ATRIPLA 33 thrombotic events 33 anaphylactic reaction 32 discontinuations 32 skin irritation 32 nasopharyngitis 32 raltegravir 32 renal insufficiency 32 ORENCIA 32 Acetaminophen

Back to home page